26/05/22
2026/05/22
管理员
New progress has been made in near-infrared II (NIR-II) photoacoustic dual-responsive hyaluronic acid–coated nanozyme–based targeted theranostics for glioblastoma. Researchers Wu Xilong and Wu Yundi f
Learn More26/05/22
2026/05/22
管理员
New progress has been made in the study of osimertinib resistance mechanisms in EGFR-mutant non-small cell lung cancer (NSCLC). Research teams led by Richeng Jiang and Dingzhi Huang from Tianjin Medic
Learn More26/05/14
2026/05/14
管理员
New progress has been made in the development of targeted nanomedicines for peritoneal metastasis of colorectal cancer.
Learn More26/05/14
2026/05/14
管理员
New progress has been made in organelle therapy based on mitochondrial capsule delivery systems for the treatment of Parkinson’s disease and other mitochondrial dysfunction-related disorders.
Learn More26/05/04
2026/05/04
管理员
New progress has been made in multifunctional nanocatalytic tumor theranostics.
Learn More26/05/04
2026/05/04
管理员
New progress has been made in the molecular regulatory mechanisms of poplar resistance to rust fungi.
Learn More26/04/28
2026/04/28
管理员
New progress has been made in skin wound repair and regenerative medicine, particularly through the regulation of macrophage polarization.
Learn More26/04/28
2026/04/28
管理员
From April 17 to 22, 2026, the Annual Meeting of the American Association for Cancer Research (AACR) was held at the San Diego Convention Center in California, USA.
Learn More